Parkinson's Progression Marker Initiative (PPMI) Online identifies people with features of prodromal Parkinson's Disease through online questionnaires

被引：0
|
作者：
Brown, E.
Chahine, L.
Alonso, D.
Coffey, C.
Dobkin, R.
Foroud, T.
Korell, M.
Lorenzo, A.
Marras, C.
Poewe, W.
Sherer, T.
Siderowf, A.
Simuni, T.
Tolosa, E.
Twiggs, J. Valverde
Weintraub, D.
Chowdhury, S.
Marek, K.
Tanner, C.
机构：
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1176
引用
收藏
页码：S516 / S516
页数：1
相关论文
共 50 条
  • [1] Parkinson's Progression Markers Initiative (PPMI) Online Expands Biomarker Research in Parkinson's Disease (PD)
    Brown, Ethan
    Alonso, David
    Chahine, Lana
    Coffey, Christopher
    Dobkin, Roseanne
    Korell, Monica
    Lorenzo, Ana
    Marras, Connie
    Poewe, Werner
    Sherer, Todd
    Siderowf, Andrew
    Simuni, Tanya
    Tolosa, Eduardo
    Twiggs, Julien Valverde
    Weintraub, Daniel
    Chowdhury, Sohini
    Marek, Kenneth
    Tanner, Caroline
    MOVEMENT DISORDERS, 2022, 37 : S3 - S4
  • [2] Parkinson's Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson's disease (PD)
    Brown, E.
    Alonso, D.
    Chahine, L.
    Coffey, C.
    Dobkin, R.
    Korell, M.
    Lorenzo, A.
    Marras, C.
    Poewe, W.
    Sherer, T.
    Siderowf, A.
    Simuni, T.
    Tolosa, E.
    Twiggs, J. Valverde
    Weintraub, D.
    Chowdhury, S.
    Marek, K.
    Tanner, C.
    MOVEMENT DISORDERS, 2022, 37 : S516 - S517
  • [3] Online Recruitment and Retention in the Parkinson's Progression Markers Initiative (PPMI)
    Tanner, C.
    Brown, E.
    Chahine, L.
    Weintraub, D.
    Dobkin, R.
    Poewe, W.
    Tolosa, E.
    Marras, C.
    Schade, S.
    Coffey, C.
    Korell, M.
    Stanley, C.
    Twiggs, J. Valdeverde
    Kuhl, M.
    Fabrizio, K.
    Chowdhury, S.
    Sherer, T.
    Siderowf, A.
    Simuni, T.
    Marek, K.
    MOVEMENT DISORDERS, 2023, 38 : S53 - S54
  • [4] The Parkinson Progression Marker Initiative (PPMI)
    Marek, Kenneth
    Jennings, Danna
    Lasch, Shirley
    Siderowf, Andrew
    Tanner, Caroline
    Simuni, Tanya
    Coffey, Chris
    Kieburtz, Karl
    Flagg, Emily
    Chowdhuty, Sohini
    Poewe, Werner
    Mollenhauer, Brit
    Sherer, Todd
    Frasier, Mark
    Meunier, Claire
    Rudolph, Alice
    Casaceli, Cindy
    Seibyl, John
    Mendick, Susan
    Schuff, Norbert
    Zhang, Ying
    Toga, Arthur
    Crawford, Karen
    Ansbach, Alison
    Piovella, Michele
    Trojanowski, John
    Shaw, Les
    Singleton, Andrew
    Hawkins, Keith
    Eberling, Jamie
    Brooks, Deborah
    Russell, David
    Leary, Laura
    Factor, Stewart
    Sommerfeld, Barbara
    Hogarth, Penelope
    Pighetti, Emily
    Williams, Karen
    Standaert, David
    Guthrie, Stephanie
    Hauser, Robert
    Delgado, Holly
    Jankovic, Joseph
    Hunter, Christine
    Stern, Matthew
    Baochan Tran
    Leverenz, Jim
    Baca, Marne
    Frank, Sam
    Thomas, Cathi-Ann
    PROGRESS IN NEUROBIOLOGY, 2011, 95 (04) : 629 - 635
  • [5] The Parkinson Progression Marker Initiative (PPMI)
    Trojanowski, John
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (06): : 546 - 547
  • [6] Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
    Prakash, Neha
    Caspell-Garcia, Chelsea
    Coffey, Christopher
    Siderowf, Andrew
    Tanner, Caroline M.
    Kieburtz, Karl
    Mollenhauer, Brit
    Galasko, Douglas
    Merchant, Kalpana
    Foroud, Tatiana
    Chahine, Lana M.
    Weintraub, Daniel
    Casaceli, Cindy
    Dorsey, Ray
    Wilson, Renee
    Herzog, Margaret
    Daegele, Nichole
    Arnedo, Vanessa
    Frasier, Mark
    Sherer, Todd
    Marek, Ken
    Frank, Samuel
    Jennings, Danna
    Simuni, Tanya
    Marek, Kenneth
    Siderowf, Andrew
    Seibyl, John
    Coffey, Christopher
    Tanner, Caroline
    Tosun-Turgut, Duygu
    Simunir, Tanya
    Shaw, Leslie
    Trojanowski, John
    Singleton, Andrew
    Kieburtz, Karl
    Toga, Arthur
    Mollenhauer, Brit
    Galasko, Douglas
    Poewe, Werner
    Foroud, Tatiana
    Poston, Kathleen
    Sherer, Todd
    Chowdhury, Sohini
    Frasier, Mark
    Kopil, Catherine
    Arnedo, Vanessa
    Daegele, Nichole
    Casaceli, Cynthia
    Dorsey, Ray
    Wilson, Renee
    PARKINSONISM & RELATED DISORDERS, 2019, 62 : 201 - 209
  • [7] The Parkinson's progression marker initiative (PPMI) - Developing a sample size estimate for Parkinson's disease therapeutic trials
    MOVEMENT DISORDERS, 2015, 30 : S428 - S429
  • [8] Baseline neuroimaging characteristics of the Parkinson's progression marker initiative (PPMI) Parkinson's and healthy cohorts
    Seibyl, J. P.
    MOVEMENT DISORDERS, 2012, 27 : S255 - S256
  • [9] Association between CSF biomarkers and clinical phenotype of early Parkinson's disease in the Parkinson's Progression Marker Initiative (PPMI)
    Kang, J. H.
    Caspell, C.
    Coffey, C.
    Taylor, P.
    Frasier, M.
    Marek, K.
    Trojanowski, J. Q.
    Shaw, L. M.
    MOVEMENT DISORDERS, 2012, 27 : S34 - S35
  • [10] 123-I ioflupane SPECT measures of Parkinson's disease progression in the Parkinson Progression Marker Initiative (PPMI) trial
    Seibyl, J. P.
    Jennings, D.
    Grachev, I. D.
    Coffey, C.
    Marek, K. L.
    MOVEMENT DISORDERS, 2013, 28 : S60 - S61
12345